Clopidogrel Bisulfate/Omeprazole

硫酸氢氯吡格雷/奥美拉唑

Report date: 2022/11/25 17:43:19

Base Information

Drug NameClopidogrel Bisulfate/Omeprazole
Drug Alias NameClopidogrel Bisulfate and Omeprazole奥美拉唑硫酸氢氯吡格雷奥美拉唑/硫酸氢氯吡格雷Clopidogrel/OmeprazoleOmeprazole/Clopidogrel Bisulfate +[8] 
ClassificationSmall molecules
Mechanisms of ActionPurinergic receptor P2Y12 antagonistsProton pump inhibitors
TargetsProton pumpPurinergic receptor P2Y12
Therapy Area/IndicationsMyocardial InfarctionCoronary Artery DiseaseAcute Coronary Syndrome +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[16] 
CombinationsYes Clopidogrel BisulfateOmeprazole
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCogentus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCogentus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionCoronary Artery DiseaseAcute Coronary Syndrome +[4] 

Other Information

ATC CodeN/A
Related LinksN/A